Planet 13 Holdings (PLNH) EBT Growth (1y) (2022 - 2026)
Planet 13 Holdings (PLNH) EBT Growth (1y) (2022 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.98 Bn | 43.02 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.28 Bn | 39.62 Bn | 2.15 Bn | -324.14% |
| 3 | Zoetis | 31.78 Bn | 30.11 Bn | 1.05 Bn | -5.04% |
| 4 | Takeda Pharmaceutical | 28.71 Bn | 22.91 Bn | 5.10 Bn | -1.93% |
| 5 | United Therapeutics | 22.25 Bn | 19.59 Bn | 683.80 Mn | -8.74% |
| 6 | Viatris | 18.72 Bn | 17.83 Bn | 1.46 Bn | 70.52% |
| 7 | Neurocrine Biosciences | 15.57 Bn | 15.18 Bn | 935.80 Mn | 1.69% |
| 8 | Elanco Animal Health | 11.87 Bn | 11.34 Bn | 798.00 Mn | 124.00% |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.97 Bn | - | - |
| 10 | Planet 13 Holdings | 47.95 Mn | 31.46 Mn | 12.32 Mn | 60.48% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 60.48% |
| Mar 31, 2026 | -115.73% |
| Dec 31, 2025 | 98.20% |
| Sep 30, 2025 | -1,377.05% |
| Jun 30, 2025 | -70.99% |
| Mar 31, 2025 | 48.63% |
| Dec 31, 2024 | -144.35% |
| Sep 30, 2024 | 93.35% |
| Jun 30, 2024 | -129.42% |
| Mar 31, 2024 | 42.58% |
| Dec 31, 2023 | 75.04% |
| Sep 30, 2023 | -970.45% |
| Jun 30, 2023 | 58.03% |
| Mar 31, 2023 | -371.16% |
| Dec 31, 2022 | -859.23% |
| Sep 30, 2022 | -724.87% |
| Jun 30, 2022 | -60.16% |
| Mar 31, 2022 | 52.31% |